Bevacizumab (Avastin) treatment for severe hepatic encephalopathy in a patient with hereditary hemorrhagic telangiectasia

Mei-Zahav, M; Issachar, A; Rosengarten, D; Kramer, M; Brown, M; Blau, H

ANGIOGENESIS, 2018; 21 (1): 135